Medical Risk Law Weekly News

Week of: February 18, 2019

IN THE NEWS


Illegal Products Claim to Treat Alzheimer’s Disease

On February 11, 2019, the FDA posted 12 warning letters and five online advisory letters issued to foreign and domestic companies that are illegally selling more than 58 products, many that are sold as dietary supplements, which are unapproved new drugs and/or misbranded drugs that claim to prevent, treat, or cure Alzheimer’s disease and a number of other serious diseases and health conditions. These products, which are often sold on websites and social media platforms, have not been reviewed by the FDA and are not proven safe and effective to treat the diseases and health conditions they claim to treat. These products may be ineffective and unsafe. Using these products could prevent a person from seeking an appropriate diagnosis and treatment. Click title to continue reading...


 
MEDICAL ALERTS


Consent Decree against Drug Compounder; Insanitary Conditions

On February 6, 2019, the U.S. District Court for the Western District of Pennsylvania entered a consent decree of permanent injunction between the United States and Ranier’s Rx Laboratory Inc., doing business as Ranier’s Compounding Laboratory, of Jeanette, Pennsylvania, and pharmacist Francis H. Ranier, who owns the compounding facility. Click title to continue reading...



Drug Supply Chain Security; Tracking and Tracing of Medicines

On February 7, 2019, the FDA launched a new pilot project in which participants representing the drug supply chain (e.g., manufacturers, repackagers, and other stakeholders) can pilot the use of innovative and emerging approaches for enhanced tracing and verification of prescription drugs in the U.S. to ensure suspect and illegitimate products do not enter the supply chain. Click title to continue reading...



Awareness of Heart Attack Symptoms and Response

On February 8, 2019, the CDC published a report that found that knowledge of five common signs and symptoms of a heart attack and the appropriate emergency response increased significantly (from 40 percent to 50 percent and from 92 percent to 95 percent, respectively). However, sociodemographic disparities in knowledge persist. Click title to continue reading...


  CASE ALERTS


Stem Cell Transplant Informed Consent; Failure to Treat Sepsis

A patient with a complex medical history was under the care of two physicians during an admission to a hospital. The patient was administered chemotherapy. Click title to continue reading...



Failure to Diagnose Meningioma (Brain Membrane Tumor)

A patient presented to an ophthalmologist complaining of eye pain, trouble focusing, and drooping right upper eyelid. After examining the patient and performing tests, the ophthalmologist suspected that the patient was suffering from glaucoma and instructed the patient to return in six months for additional tests, or sooner if the symptoms worsened or failed to improve. Click title to continue reading...



Concentration, Persistence, Pace in Residual Functional Capacity

A claimant applied for disability insurance benefits and supplemental security income claiming disability based on numerous conditions, including degenerative disc disease, osteoarthritis, hypertension, COPD, and anxiety. Click title to continue reading...


FEATURE


Risk Manager Checklist: Duty of Care – Hernia

As a special feature for our Premium subscribers, we have included this checklist as guidance for hospital and outpatient clinic risk managers determining the appropriate policies and training to put in place in order to reduce the risk of malpractice and negligence claims related to the diagnosis and treatment of hernia. Click title to continue reading...